51 related articles for article (PubMed ID: 22715137)
1. The effects of ultrasound and light on indocyanine-green-treated tumour cells and tissues.
Nomikou N; Sterrett C; Arthur C; McCaughan B; Callan JF; McHale AP
ChemMedChem; 2012 Aug; 7(8):1465-71. PubMed ID: 22715137
[TBL] [Abstract][Full Text] [Related]
2. Oligo(styryl)benzenes liposomal AIE-dots for bioimaging and phototherapy in an in vitro model of prostate cancer.
Vázquez-Villar V; Das C; Swift T; Elies J; Tolosa J; García-Martínez JC; Ruiz A
J Colloid Interface Sci; 2024 Sep; 670():585-598. PubMed ID: 38776693
[TBL] [Abstract][Full Text] [Related]
3. Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer.
Browning RJ; Able S; Ruan JL; Bau L; Allen PD; Kersemans V; Wallington S; Kinchesh P; Smart S; Kartsonaki C; Kamila S; Logan K; Taylor MA; McHale AP; Callan JF; Stride E; Vallis KA
J Control Release; 2021 Sep; 337():371-377. PubMed ID: 34274382
[TBL] [Abstract][Full Text] [Related]
4. Treating cancer with sonodynamic therapy: a review.
Costley D; Mc Ewan C; Fowley C; McHale AP; Atchison J; Nomikou N; Callan JF
Int J Hyperthermia; 2015 Mar; 31(2):107-17. PubMed ID: 25582025
[TBL] [Abstract][Full Text] [Related]
5. Current status and future perspectives of sonodynamic therapy in glioma treatment.
Wang X; Jia Y; Wang P; Liu Q; Zheng H
Ultrason Sonochem; 2017 Jul; 37():592-599. PubMed ID: 28427672
[TBL] [Abstract][Full Text] [Related]
6. Organic Sonosensitizers for Sonodynamic Therapy: From Small Molecules and Nanoparticles toward Clinical Development.
Li D; Yang Y; Li D; Pan J; Chu C; Liu G
Small; 2021 Oct; 17(42):e2101976. PubMed ID: 34350690
[TBL] [Abstract][Full Text] [Related]
7. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Sonodynamic Treatment Set-Ups for Cancer Cells with Organic Sonosensitizers and Nanosonosensitizers.
Radivoievych A; Prylutska S; Zolk O; Ritter U; Frohme M; Grebinyk A
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004594
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity.
Wang C; Zhang R; He J; Yu L; Li X; Zhang J; Li S; Zhang C; Kagan JC; Karp JM; Kuai R
Nat Commun; 2023 Jun; 14(1):3877. PubMed ID: 37391428
[TBL] [Abstract][Full Text] [Related]
10. Microfluidic Generation of Near-Infrared Photothermal Vitexin/ICG Liposome with Amplified Photodynamic Therapy.
Cao X; Liu Q; Adu-Frimpong M; Shi W; Liu K; Deng T; Yuan H; Weng X; Gao Y; Yu Q; Deng W; Yu J; Wang Q; Xiao G; Xu X
AAPS PharmSciTech; 2023 Mar; 24(4):82. PubMed ID: 36949351
[TBL] [Abstract][Full Text] [Related]
11. Current status and future perspective of sonodynamic therapy for cancer.
Sofuni A; Itoi T
J Med Ultrason (2001); 2022 Oct; ():. PubMed ID: 36224458
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-triggered oxygen-loaded nanodroplets enhance and monitor cerebral damage from sonodynamic therapy.
Lea-Banks H; Wu SK; Lee H; Hynynen K
Nanotheranostics; 2022; 6(4):376-387. PubMed ID: 35795341
[TBL] [Abstract][Full Text] [Related]
13. Deep-Tissue Activation of Photonanomedicines: An Update and Clinical Perspectives.
Shah N; Squire J; Guirguis M; Saha D; Hoyt K; Wang KK; Agarwal V; Obaid G
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454910
[TBL] [Abstract][Full Text] [Related]
14. Engineered extracellular vesicle-based sonotheranostics for dual stimuli-sensitive drug release and photoacoustic imaging-guided chemo-sonodynamic cancer therapy.
Nguyen Cao TG; Kang JH; Kim W; Lim J; Kang SJ; You JY; Truong Hoang Q; Kim WJ; Rhee WJ; Kim C; Ko YT; Shim MS
Theranostics; 2022; 12(3):1247-1266. PubMed ID: 35154485
[TBL] [Abstract][Full Text] [Related]
15. Metal complexation-mediated stable and biocompatible nanoformulation of clinically approved near-infrared absorber for improved tumor targeting and photonic theranostics.
Lee YD; Shin HJ; Yoo J; Kim G; Kang MK; Lee JJ; Bang J; Yang JK; Kim S
Nano Converg; 2021 Nov; 8(1):36. PubMed ID: 34757544
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in sono-photodynamic cancer therapy: From developed new sensitizers to nanotechnology-based efficacy-enhancing strategies.
Zheng Y; Ye J; Li Z; Chen H; Gao Y
Acta Pharm Sin B; 2021 Aug; 11(8):2197-2219. PubMed ID: 34522584
[TBL] [Abstract][Full Text] [Related]
17. Design and Challenges of Sonodynamic Therapy System for Cancer Theranostics: From Equipment to Sensitizers.
Gong Z; Dai Z
Adv Sci (Weinh); 2021 May; 8(10):2002178. PubMed ID: 34026428
[TBL] [Abstract][Full Text] [Related]
18. Investigating the performance of a novel pH and cathepsin B sensitive, stimulus-responsive nanoparticle for optimised sonodynamic therapy in prostate cancer.
Hadi MM; Nesbitt H; Masood H; Sciscione F; Patel S; Ramesh BS; Emberton M; Callan JF; MacRobert A; McHale AP; Nomikou N
J Control Release; 2021 Jan; 329():76-86. PubMed ID: 33245955
[TBL] [Abstract][Full Text] [Related]
19. The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells.
Xie W; Zhu S; Yang B; Chen C; Chen S; Liu Y; Nie X; Hao L; Wang Z; Sun J; Chang S
Int J Nanomedicine; 2019; 14():9377-9393. PubMed ID: 31819438
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
